Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis — Jacopo Francesco Imberti (2021) | RDL Network
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis
Article 2021 en
Authors
JI
Jacopo Francesco Imberti
WD
Wern Yew Ding
AK
Agnieszka Kotalczyk
Abstract
1 min read
First-line treatment with CA is superior to AAD therapy in patients with symptomatic paroxysmal AF, as it significantly reduces the recurrence of any atrial arrhythmias and symptomatic atrial arrhythmias, and healthcare resource utilisation with comparable safety profile.
Demosthenes G. Katritsis, John P A Ioannidis, Constantine E. Anagnostopoulos, George E. Sarris, Eleftherios Giazitzoglou, Socrates Korovesis, A. John Camm
Mengqi Gong, Angel Cheung, Qunshan Wang, Guangping Li, Christos A. Goudis, George Bazoukis, Professor Gregory Lip, Adrián Baranchuk, Panagiotis Korantzopoulos, Κonstantinos P. Letsas, Gary Tse, Tong Liu
Aditya Vaze, Kevin Donahue, Matthew Spring, Mayank Sardana, Kahraman Tanrıverdi, Jane E. Freedman, John F. Keaney, Emelia Benjamin, Steven A. Lubitz, Lawrence Rosenthal, Kevin Floyd, David D. McManus
Discussion(0)
No comments yet. Be the first to comment.